Shankland named CMPMedica CEO

Share this article:
CMPMedica named Sally Shankland CEO of CMPMedica US, replacing Vicki Masseria.

Shankland was previously SVP of the firm's US promotional business unit, a role she served for six years. She has worked for CMPMedica owner United Business Media since 1988, when she joined Miller Freeman. She orchestrated the 2006 launch of SearchMedica. Harry Elkington, global CEO of CMPMedica, praised her “great track record in building the promotional side of our business.”
Masseria spent 26 years with CMPMedica and its predecessor companies. Through a CMPMedica spokesperson, she declined comment on her future plans.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...